These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32645089)

  • 1. Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by 18F-ICMT-11-Positron Emission Tomography.
    Witney TH; Fortt R; Aboagye EO
    PLoS One; 2020; 15(7):e0235804. PubMed ID: 32645089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLOS Staff
    PLoS One; 2018; 13(1):e0191454. PubMed ID: 29329348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    Shen G; Lan Y; Zhang K; Ren P; Jia Z
    PLoS One; 2017; 12(4):e0176150. PubMed ID: 28406970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
    PLOS ONE Staff
    PLoS One; 2021; 16(7):e0255429. PubMed ID: 34297782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
    de Jong EE; van Elmpt W; Leijenaar RT; Hoekstra OS; Groen HJ; Smit EF; Boellaard R; van der Noort V; Troost EG; Lambin P; Dingemans AC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):8-16. PubMed ID: 27600280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: correlation of the apparent diffusion coefficient (ADC) with the Standardized Uptake Value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0122545. PubMed ID: 25807190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    Bolcaen J; Lybaert K; Moerman L; Descamps B; Deblaere K; Boterberg T; Kalala JP; Van den Broecke C; De Vos F; Vanhove C; Goethals I
    PLoS One; 2016; 11(10):e0164208. PubMed ID: 27695065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.
    Otsuka M; Monzen H; Matsumoto K; Tamura M; Inada M; Kadoya N; Nishimura Y
    PLoS One; 2019; 14(11):e0225965. PubMed ID: 31774868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit.
    PLOS ONE Staff
    PLoS One; 2018; 13(2):e0192527. PubMed ID: 29394296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis.
    Nie J; Zhang J; Gao J; Guo L; Zhou H; Hu Y; Zhu C; Li Q; Ma X
    PLoS One; 2018; 13(8):e0202314. PubMed ID: 30092075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.
    Peikert T; Duan F; Rajagopalan S; Karwoski RA; Clay R; Robb RA; Qin Z; Sicks J; Bartholmai BJ; Maldonado F
    PLoS One; 2018; 13(10):e0205311. PubMed ID: 30278080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    Gupte AN; Paradkar M; Selvaraju S; Thiruvengadam K; Shivakumar SVBY; Sekar K; Marinaik S; Momin A; Gaikwad A; Natrajan P; Prithivi M; Shivaramakrishnan G; Pradhan N; Kohli R; Raskar S; Jain D; Velu R; Karthavarayan B; Lokhande R; Suryavanshi N; Gupte N; Murali L; Salvi S; Checkley W; Golub J; Bollinger R; Mave V; Padmapriyadarasini C; Gupta A
    PLoS One; 2019; 14(12):e0226389. PubMed ID: 31805169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development.
    Ferreira GS; Veening-Griffioen DH; Boon WPC; Moors EHM; Gispen-de Wied CC; Schellekens H; van Meer PJK
    PLoS One; 2019; 14(7):e0220325. PubMed ID: 31329650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of standardised uptake value (SUV
    Yilmaz Demirci N; Yilmaz Ü; Biner Uslu I; Dikmen A; Yılmaz A; Erdoğan Y
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26988938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
    Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JJ; Kuntz KW; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
    PLoS One; 2017; 12(1):e0170539. PubMed ID: 28085948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2017; 12(1):e0170833. PubMed ID: 28107536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in Chinese.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0117882. PubMed ID: 25635879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Identification of feature risk pathways of smoking-induced lung cancer based on SVM.
    Chen R; Lin J
    PLoS One; 2020; 15(7):e0235854. PubMed ID: 32609753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(8):e0183201. PubMed ID: 28793330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
    PLOS ONE Staff
    PLoS One; 2016; 11(12):e0168221. PubMed ID: 27936143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.